7152-95-6

Basic information

• Product Name: 4-BENZYLOXY-3-METHOXYCINNAMIC ACID
• Synonyms: RARECHEM AL BK 0064;BENZYL FERULIC ACID;3-(4-BENZYLOXY-3-METHOXYPHENYL)-ACRYLIC ACID;AKOS B004382;4-BENZYLOXY-3-METHOXYCINNAMIC ACID;3-[3-Methoxy-4-(phenylmethoxy)phenyl]-2-propenoic acid;3-Methoxy-4-(benzyloxy)cinnamic acid;NSC 16729
• CAS NO: 7152-95-6
• Molecular Formula: C₁₇H₁₆O₄
• Molecular Weight: 284.31
• Product Categories: Aromatic Cinnamic Acids, Esters and Derivatives
• Mol File: 7152-95-6.mol
• Article Data: 7

Chemical Properties

• Melting Point: 188 °C
• Boiling Point: 470℃
• Flash Point: 173℃
• Appearance: /
• Density: 1.216
• Vapor Pressure: 1.2E-09mmHg at 25°C
• CAS DataBase Reference: 4-BENZYLOXY-3-METHOXYCINNAMIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BENZYLOXY-3-METHOXYCINNAMIC ACID(7152-95-6)
• EPA Substance Registry System: 4-BENZYLOXY-3-METHOXYCINNAMIC ACID(7152-95-6)

Safety Data

• Hazardous Substances Data: 7152-95-6(Hazardous Substances Data)

Usage

General Description

4-Benzyloxy-3-methoxycinnamic Acid is a chemical compound that falls under the category of organic compounds known as phenylpropanoids and polyketides. These are aromatic compounds containing a phenylpropanoid moiety. This chemical substance is slightly soluble in water and typically comes in the solid form. It has potential application in various fields due to the aromatic ring in its molecular structure. However, detailed information about its use, safety, toxicity and environmental impact is unspecified, which is typical for chemical compounds that may not be in broad commercial usage.

InChI:InChI=1/C17H16O4/c1-20-16-11-13(8-10-17(18)19)7-9-15(16)21-12-14-5-3-2-4-6-14/h2-11H,12H2,1H3,(H,18,19)/p-1/b10-8+

Upstream product

• 2426-87-1 3-methoxy-4-(phenylmethoxy)benzaldehyde 
• 141-82-2 malonic acid 
• 108-24-7 acetic anhydride 
• 481701-70-6 benzyl 3-methoxy-4-benzyloxycinnamate 
• 1135-24-6 3-(4-hydroxy-3-methoxyphenyl)acrylic acid 
• 93878-20-7 3-Methoxy-4-benzyloxy-zimtsaeure-methylester 
• 22329-76-6 methyl ferulate 
• 121-33-5 vanillin 

Downstream Products

• 30034-49-2 β-(4-benzyloxy-3-methoxyphenyl)propionic acid 
• 94910-03-9 3-Methoxy-4-benzyloxy-zimtsaeure-diaethylamid 
• 1135-24-6 (E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid 
• 83608-86-0 N-trans-feruloyl-3-O-methyldopamine 
• 92324-00-0 3-(3-Methoxy-4-hydroxy-phenyl)-propionsaeure-diaethylamid 
• 108852-43-3 O-benzylferulic acid chloride 
• 1257641-95-4 (E)-4-(2-((3-(4-hydroxy-3-methoxyphenyl)acryloyl)oxy)ethoxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxide 

Relevant articles and documents

Novel Ferulic Amide Ac6c Derivatives: Design, Synthesis, and Their Antipest Activity

Thirty-eight novel ferulic amide 1-aminocyclohexane carboxylic acid (Ac6c) derivativesD1-D19andE1-E19were designed and synthesized, and their antibacterial, antifungal, and insecticidal activities were tested. Most of the synthesized compounds displayed e

Phenylsulfonylfuroxan NO-donor phenols: Synthesis and multifunctional activities evaluation

Phenylsulfonyfuroxan nitric oxide (NO)-donor phenols were designed, synthesized and evaluated. The compounds were designed through a symbiotic approach using selected phenols and phenylsulfonylfuroxan NO-donor. The antioxidant activities of the hybrid compounds T2–T6 showed to be good in vivo. Compounds T4 and T6 revealed excellent yeast α-glucosidase inhibitory activity and anti-glycosylation activity. All of the compounds exhibited strong NO releasing activity and significant anti-platelet aggregation activity. The inhibition of platelet aggregation was more than 50% at low concentration (1.5?μM) and 95% at higher concentration (15?μM and 150?μM). The vasodilatation experiment demonstrated that the six compounds under test exhibited definite vasodilation activity (pIC50 ranged from 5.698 to 6.383), especially compound T6 (pIC50 was 6.383) which was similar to sodium nitroprusside (pIC50 was 6.786). Both anticoagulant and vasodilatation effects were correlated with their NO releasing activities. These hybrid phenylsulfonyfuroxan-based NO-donor phenols offer a multifunctional prodrug design concept for the development of therapeutic or preventive agents for metabolic syndrome.

Radical scavenging activity and performance of novel phenolic antioxidants in oils during storage and frying

Novel phenolic antioxidants: 2a (6′-hydroxy-2′,5′, 7′,8′-tetramethylchroman-2′-yl)methyl 3-methoxy-4- hydroxycinnamate, 2b (6′-hydroxy-2′,5′,7′,8′- tetramethylchroman-2′-yl)methyl 3,5-dimethoxy-4-hydroxycinnamate, 2c (6′-hydroxy-2′,5′,7′,8′-tetramethylchr